Results 26 - 50 from 83 for "biofarm"
-
Biofarm Targets 15% Growth in Turnover in 2021, to RON250M
03.23.2021
Romanian pharmaceutical company Biofarm Bucuresti (BIO.RO) estimates its turnover will grow 15% in 2021 compared with 2020, to over RON250 million. more
-
Biofarm Net Profit Up 7.2% To RON54M, Sales Revenue Up 8% To RON218M YoY In 2020
02.16.2021
Biofarm Bucuresti (BIO.RO), one of the leading drugmakers in Romania, ended 2020 with a net profit of RON54.5 million, up 7.2% versus 2019, while income from sales grew 8% to RON218 million, the more
-
Marian Buica Elected Temporary Member Of Biofarm Board Of Directors
09.18.2020
Marian Buica, general manager of regional investment fund SIF Muntenia (SIF4.RO), was elected temporary member of the Board of Directors of pharmaceuticals company Biofarm, Bucuresti and is to be more
-
Biofarm Posts RON30M Net Profit in H1
08.17.2020
Pharmaceutical company Biofarm Bucuresti (BIO.RO) posted 29.8 million lei net profit in the first half, 6% higher than in the year-ago period, while revenue stood at RON106 million, up from the RON97 more
-
Biofarm Seeks To Pay Gross Dividends Of RON0.021/Share From 2019 Net Profit, At 6.3% Yield
03.24.2020
-
Biofarm Shareholders Approve Additional Dividends of RON9.8M
12.11.2019
Shareholders of pharmaceutical producer Biofarm (BIO.RO) on Wednesday approved additional dividends of RON0.01 per share, amounting to RON9.8 million. more
-
Biofarm Investments Exceed RON10M In January-June 2019
08.14.2019
-
SIF Moldova Sells All Its Shares In Biofarm To SIF Banat-Crisana
05.24.2019
-
Biofarm Net Profit Grows 46% in 1Q, to RON16.2M
05.15.2019
Romanian pharmaceutical producer Biofarm (BIO.RO) on Wednesday reported a net profit of RON16.2 million for the first quarter, up 46% compared with the same period last year. more
-
Biofarm Appoints Catalin Vicol as General Manager Starting Nov 15
09.13.2018
Romanian pharmaceutical producer Biofarm (BIO.RO), controlled by three regional investment funds, of SIFs, has appointed Catalin Vicol as general manager effective November 15. more
-
Biofarm Proposes RON18.7M Dividends At 6% Yield
03.14.2018
Romanian pharmaceutical producer Biofarm (BIO.RO) proposes the payment of a gross dividend of RON0.019 per share, at a 6.16% yield, totaling RON18.7 million, which translates into a distribution rate more
-
Biofarm 2017 Turnover Up 12% At RON170M; Net Profit Up 24% At RON36M
01.31.2018
-
SIF Banat-Crisana Increases Stake In Biofarm By 1.16%
09.21.2016
Romanian regional investment fund SIF Banat-Crisana (SIF1.RO) has recently bought a stake of 11.44 million shares of pharmaceutical producer Biofarm Bucuresti (BIO.RO), which represents 1.16% of the more
-
Biofarm Profit Up 1% To RON15.2M In 1H
08.12.2016
Romanian pharmaceutical producer Biofarm (BIO.RO) reported a profit of RON15.2 million in the first six months of the year, up 1% compared with January-June 2015, the company said Friday. more
-
Biofarm Profit Drops 52% To RON6.5M In 1Q
05.17.2016
Romanian pharmaceutical producer Biofarm (BIO.RO) reported a profit of RON6.49 million in the first quarter of the year, down 52% compared with January-March 2015, the company said on Tuesday. more
-
Biofarm Eyes RON150M Sales In 2016
05.04.2016
Romanian pharmaceutical producer Biofarm (BIO.RO) targets sales of RON150.8 million, exploitation expenses of RON122 million and an operating profit of RON28.8 million this year. more
-
Biofarm Sales Up 16% To RON150M In 2015
02.16.2016
Romanian pharmaceutical producer Biofarm (BIO.RO) reported sales of RON149.7 million (EUR33.7 million) in 2015, up 16% compared with RON128.9 million a year before, the company said in a statement. more
-
SIF Muntenia Is Biofarm’s Majority Stockholder On Ransomed Stake Cancelation
09.02.2015
Romanian regional investment fund SIF Muntenia (SIF4.RO) owns a stake of over 50% in Romanian pharmaceutical producer Biofarm (BIO.RO), on the company’s share capital decreasing after the more
-
SIF Banat-Crisana Buys 16% Stake In Biofarm
08.26.2015
Regional investment fund SIF Banat-Crisana (SIF1.RO) bought a 16.8% stake in Romanian pharmaceutical producer Biofarm (BIO.RO) for 51,000 lei, on the Bucharest Stock Exchange’s August 24 session, more
-
Biofarm Net Profit Up 2% to RON15M In First Half
08.13.2015
Romanian pharmaceutical producer Biofarm (BIO.RO) Thursday reported a first-half net profit of 15 million lei (EUR3.4 million), slightly up from RON14.7 million in the year-earlier period. more
-
Biofarm Reports 37% Higher Net Profit in 1Q
05.17.2015
Romanian medicine producer Biofarm (BIO.RO) reported a net profit of 13.6 million lei (EUR3 million) for the first quarter, up 37.3% from the year earlier period, on higher sales. more
-
Biofarm Goes Shopping, Wants To Earmark RON14M For Acquisitions
04.07.2015
Romanian drug maker Biofarm Bucuresti (BIO.RO) wants to acquire a pharmaceutical company to gain market share and grow its own business. more
-
Biofarm Sales Rose 9.5% Last Year, To RON128.9M
02.12.2015
Sales of pharmaceutical manufacturer Biofarm (BIO.RO) rose 9.5% last year, to RON128.9 million (around EUR29.1 million), while the company's net profit grew 2%, to RON26.1 million (EUR5.9 million. more
-
Biofarm 9-Month Sales Up 4.6% On Year, To RON88.5M
11.14.2014
Romanian drugmaker Biofarm (BIO.RO) Friday said its sales rose 4.6% to 89.48 million lei (EUR20.2 million) in the first nine months of 2014, from RON85.57 million in the same period in 2013. more
-
Biofarm Buyback Offer Largely Oversubscribed
09.15.2014
The buyback offer launched by pharmaceutical producer Biofarm (BIO.RO) on the Bucharest stock exchange was heavily oversubscribed, as the company’s main shareholders placed orders to sell their more